Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[International bone marrow donor exchange].

G Ehninger1, S F Goldmann

  • 1Medizinische Universitätsklinik, Tübingen.

Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prognostic potential of monitoring disease dynamics in NPM1-positive acute myeloid leukemia.

Leukemia·2019
Same author

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis.

Journal of internal medicine·2018
Same author

Net reclassification improvement with serial biomarkers and bed-sided spirometry to early predict the need of organ support during the early post-transplantation in-hospital stay in allogeneic HCT recipients.

Bone marrow transplantation·2018
Same author

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants.

Biomolecular detection and quantification·2018
Same author

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

Journal of internal medicine·2017

Unrelated donor bone marrow transplants offer up to 50% survival for chronic myelogenous leukemia. Limited HLA-A, -B, -DR typed donors in Europe hinder successful searches, impacting patient outcomes.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation

Background:

  • Over 200 unrelated donor bone marrow transplants have been performed globally.
  • Survival rates reaching 50% have been reported for chronic myelogenous leukemia patients.
  • Human Leukocyte Antigen (HLA) typing is crucial for donor matching.

Purpose of the Study:

  • To assess the success rates of unrelated donor bone marrow transplants.
  • To identify challenges in donor selection, particularly in Europe.
  • To propose strategies for improving donor availability.

Main Methods:

  • Review of worldwide bone marrow transplant data.
  • Analysis of donor pool characteristics and HLA-A, -B, -DR typing prevalence in Europe.
  • Evaluation of donor search success rates.

Related Experiment Videos

Main Results:

  • Worldwide, over 200 unrelated donor bone marrow transplants have been conducted.
  • Survival rates of up to 50% are achievable for chronic myelogenous leukemia patients.
  • Donor search success in Europe is limited to 13% due to a scarcity of HLA-A, -B, -DR typed donors.

Conclusions:

  • Unrelated donor bone marrow transplantation is a viable option for certain leukemias.
  • The limited availability of HLA-typed donors in Europe presents a significant barrier.
  • International donor searches and expanded national donor registries are essential to improve patient access to life-saving transplants.